EPIX230421C00002500 Option on ESSA Pharma
| EPIX Stock | USD 6.25 0.15 2.34% |
ESSA Pharma's option chain provides insight into all available option contracts written on ESSA Pharma's stock. Investors can see outstanding put and call contracts with pricing information and greeks for a given expiration period. In addition, each of ESSA Pharma's stock options below provides a detailed picture of the payoff. Comparing vital and dynamic information of various option contracts across diverse expiration periods will help you make an educated decision on your market timing strategies around investing in a given ESSA option contract.
In The Money vs. Out of Money Option Contracts on ESSA Pharma
Analyzing ESSA Pharma's in-the-money options over time can help investors to take a profitable long position in ESSA Pharma regardless of its overall volatility. This is especially true when ESSA Pharma's options are deep in the money. These options can be identified using deltas that are over 0.75. Deep in-the-money ESSA Pharma's options could be used as guardians of the underlying stock as they move almost dollar for dollar with ESSA Pharma's stock while costing only a fraction of its price.
ESSA Pharma's latest option contracts expiring on 2024-05-17 are carrying combined implied volatility of 136.45 with a put-to-call open interest ratio of 0.89 over 14 outstanding agreements suggesting investors are buying slightly more calls than puts on contracts expiring on 2024-05-17. The current put volume is at 0, with calls trading at the volume of 13. This yields a 0.0 put-to-call volume ratio. The ESSA Pharma option chain provides detailed quote and price information for the current ESSA Pharma option contracts. It shows all of ESSA Pharma's listed puts, calls, expiration dates, strike prices, and other pricing information.
Open Interest Against 2024-05-17 Option Contracts
ESSA Pharma option prices can potentially be used to forecast stock returns because most option chains provide information not only about the current prices but also about the future conditions in ESSA Pharma's lending market. For example, when ESSA Pharma's puts are not actively trading or completely missing in the marketplace, investors can use it to internalize expected shorting costs. So if an investor is writing a put option on ESSA Pharma, he or she must hedge the risk by shorting ESSA Pharma stock over its option's life.
2024-05-17
The chart above shows ESSA Pharma's distribution of open interest by maturity on contracts that have not yet been settled. The area between the two highest points is the projection of the price at expiration. ESSA Pharma's open interest chart also provides vital information regarding the liquidity of an option. If there is no open interest for ESSA Pharma's option, there is no secondary market available for investors to trade.
ESSA Pharma's stock options are financial instruments that give investors the right to buy or sell shares of ESSA Pharma common stock at a specified price for a given time period. Generally speaking, an option to purchase or sell ESSA stock makes it part of the underlying stock when the option's price is tied to the movement of the underlying stock. If ESSA Pharma's stock price goes up or down, the stock options follow.
Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. Please note that buying 'in-the-money' options on ESSA Pharma lessens the impact of time decay, as they carry both intrinsic and time value. So, even if ESSA Pharma's value remains static through the expiration date, the investor can sell to close an 'in-the-money' option to avoid a potential loss. However, in-the-money ESSA Pharma contracts are usually more expensive to enter than their out-of-the-money counterparts. So keep in mind that while the payoffs on an in-the-money trade can be high, the investors could ultimately experience a more consequential loss if ESSA Stock moves the wrong way.
At this time, ESSA Pharma's Total Stockholder Equity is fairly stable compared to the past year. Common Stock Total Equity is likely to rise to about 158.3 M in 2024, whereas Capital Stock is likely to drop slightly above 198.2 M in 2024. ESSA Pharma In The Money Call Balance
When ESSA Pharma's strike price is surpassing the current stock price, the option contract against ESSA Pharma stock is said to be in the money. When it comes to buying ESSA Pharma's options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on ESSA Pharma are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
ESSA Current Options Market Mood
ESSA Pharma's open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps ESSA Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Open Interest
Put-to-Call Volume
Most options investors, including buyers and sellers of ESSA Pharma's calls and puts, are not very successful. It is estimated that an average options trader loses somewhere between 80% to 90% of the time. ESSA Pharma's option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction. Using current ESSA Pharma's option volume and open interest to make an investment decision is considered a contrarian-sentiment measure that can be utilized in many timing strategies in both derivative and spot marketplace.
Rule 16 of the current ESSA contract
Base on the Rule 16, the options market is currently suggesting that ESSA Pharma will have an average daily up or down price movement of about 8.53% per day over the life of the 2024-05-17 option contract. With ESSA Pharma trading at USD 6.25, that is roughly USD 0.53. If you think that the market is fully incorporating ESSA Pharma's daily price movement you should consider buying ESSA Pharma options at the current volatility level of 136.45%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
ESSA |
Purchasing ESSA Pharma options can give investors a meaningful hedge against losses and, therefore, could be used conservatively to decrease the volatility of your portfolio. However, many options could also amount to little more than gambling, significantly enhancing your overall portfolio risk. One simple example of these aggressive strategies is the sale of "uncovered" ESSA calls. Remember, the seller must deliver ESSA Pharma stock to the call owner when a call is exercised.
ESSA Pharma Option Chain
When ESSA Pharma's strike price is surpassing the current stock price, the option contract against ESSA Pharma stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
ESSA Pharma's option chain is a display of a range of information that helps investors for ways to trade options on ESSA. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for ESSA. It also shows strike prices and maturity days for a ESSA Pharma against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Delta | Gamma | Open Int | Expiration | Current Spread | Last Price | |||
Call | 2024-05-17 CALL at $2.5 | 0.9175 | 0.0201 | 0 | 2024-05-17 | 2.45 - 6.4 | 0.0 | In |
Call | 2024-05-17 CALL at $5.0 | 0.7604 | 0.0698 | 0 | 2024-05-17 | 1.3 - 3.4 | 0.0 | In |
Call | 2024-05-17 CALL at $7.5 | 0.3889 | 0.1749 | 10 | 2024-05-17 | 0.2 - 1.1 | 0.5 | Out |
Call | 2024-05-17 CALL at $10.0 | 0.2326 | 0.1036 | 20 | 2024-05-17 | 0.05 - 0.6 | 0.15 | Out |
Put | 2024-05-17 PUT at $7.5 | -0.5808 | 0.1564 | 33 | 2024-05-17 | 1.1 - 2.3 | 1.5 | In |
Put | 2024-05-17 PUT at $10.0 | -0.8151 | 0.1036 | 0 | 2024-05-17 | 3.2 - 4.4 | 0.0 | In |
Put | 2024-05-17 PUT at $12.5 | -0.4588 | 0.0491 | 0 | 2024-05-17 | 4.0 - 8.0 | 0.0 | In |
Put | 2024-05-17 PUT at $17.5 | -0.5656 | 0.0489 | 0 | 2024-05-17 | 9.6 - 12.5 | 0.0 | In |
ESSA Pharma Total Stockholder Equity Over Time
The total equity held by shareholders, calculated as the difference between a company's total assets and total liabilities. It represents the net value of the company owned by shareholders. Total Stockholder Equity |
| Timeline |
ESSA Total Stockholder Equity
Total Stockholder Equity |
|
Be your own money manager
Our tools can tell you how much better you can do entering a position in ESSA Pharma without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run My Watchlist Analysis Now
My Watchlist AnalysisAnalyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like |
| All Next | Launch Module |
ESSA Pharma Corporate Directors
ESSA Pharma corporate directors refer to members of an ESSA Pharma board of directors. The board of directors generally takes responsibility for the ESSA Pharma's affairs and long-term direction of the entity. A corporate director does not make decisions for the corporation on his own. As a member of the board of directors, she or he must function as a part of a group that makes decisions on behalf of the business only by the board of directors' meetings. To pass a resolution, a majority of ESSA Pharma's board members must vote for the resolution. The ESSA Pharma board of directors' duties also include the election, removal, and supervision of officers, including the adoption, amendment, and repeal of bylaws.| Gary Sollis | Independent Director | Profile | |
| Marianne Sadar | Chief Scientific Officer and Director | Profile | |
| Franklin Berger | Independent Director | Profile | |
| Raymond Andersen | Chief Technical Officer, Secretary and Director | Profile |
Already Invested in ESSA Pharma?
The danger of trading ESSA Pharma is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of ESSA Pharma is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than ESSA Pharma. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile ESSA Pharma is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether ESSA Pharma offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of ESSA Pharma's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Essa Pharma Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Essa Pharma Stock: Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in ESSA Pharma. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in gross domestic product. For more information on how to buy ESSA Stock please use our How to Invest in ESSA Pharma guide.You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Complementary Tools for ESSA Stock analysis
When running ESSA Pharma's price analysis, check to measure ESSA Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ESSA Pharma is operating at the current time. Most of ESSA Pharma's value examination focuses on studying past and present price action to predict the probability of ESSA Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ESSA Pharma's price. Additionally, you may evaluate how the addition of ESSA Pharma to your portfolios can decrease your overall portfolio volatility.
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Sectors List of equity sectors categorizing publicly traded companies based on their primary business activities | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is ESSA Pharma's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ESSA Pharma. If investors know ESSA will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ESSA Pharma listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.59) | Return On Assets (0.13) | Return On Equity (0.17) |
The market value of ESSA Pharma is measured differently than its book value, which is the value of ESSA that is recorded on the company's balance sheet. Investors also form their own opinion of ESSA Pharma's value that differs from its market value or its book value, called intrinsic value, which is ESSA Pharma's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ESSA Pharma's market value can be influenced by many factors that don't directly affect ESSA Pharma's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ESSA Pharma's value and its price as these two are different measures arrived at by different means. Investors typically determine if ESSA Pharma is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ESSA Pharma's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.